Effect of cigarette smoking on duloxetine metabolism. Case study Case report
Main Article Content
Abstract
This article presents a case of a patient, which shows that there is an interaction between cigarette smoking and duloxetine metabolism and how this connection can affect treatment efficacy.
Article Details
Issue
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
1. Oliveira P, Ribeiro J, Donato H et al. Smoking and antidepressants pharmacokinetics: a systematic review. Ann Gen Psychiatry. 2017; 16(1): 17.
2. Łoza B, Jahnz-Różyk K, Karkowska D et al. Możliwości realizacji programu redukcji szkód u osób palących tytoń. Stan aktualny i rekomendacje. Neuropsychiatria. 2019; 11(3-4): 41-50.
3. Tancredi N, Kohli N. Smoking cessation and duloxetine toxicity: A case report. J Am Pharm Assoc. 2020. https://doi. org/10.1016/j.japh.2020.01.003.
2. Łoza B, Jahnz-Różyk K, Karkowska D et al. Możliwości realizacji programu redukcji szkód u osób palących tytoń. Stan aktualny i rekomendacje. Neuropsychiatria. 2019; 11(3-4): 41-50.
3. Tancredi N, Kohli N. Smoking cessation and duloxetine toxicity: A case report. J Am Pharm Assoc. 2020. https://doi. org/10.1016/j.japh.2020.01.003.